Sign inJoin waitlistJoin the waitlist

Theodore Nowicki

Assistant Professor, Department of Pediatrics, Hematology/Oncology · UCLA David Geffen School of Medicine/UCLA Medical Center

Credentials: · · ·

History

UCLA David Geffen School of Medicine/UCLA Medical Center
Present

Pediatric Hematology/Oncology
UCLA David Geffen School of Medicine/UCLA Medical Center
2016–2019
Pediatrics
UCLA David Geffen School of Medicine/UCLA Medical Center
2013–2016
New York Medical College
2009–2013

Research

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort…
The Lancet Oncology · 2018 · 579 citations
Mechanisms of Resistance to PD-1 and PD-L1 Blockade
Review · The Cancer Journal · 2018 · First of 3 authors · 330 citations
Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations
Clinical Cancer Research · 2018 · 321 citations

Antoni Ribas
16 papers
Arun Singh
5 papers
Noah Federman
5 papers
Bartosz Chmielowski
4 papers
Siwen Hu-Lieskovan
4 papers · 4 as a fellow
SS
Stimson Schantz
4 papers
Anusha Kalbasi
3 papers
AM
Augustine Moscatello
3 papers
CS
Claudio Sandoval
3 papers
Edward Shin
3 papers
Jennifer McQuade
3 papers · 2 as a fellow
Michael Davies
3 papers

Grants

TNF-Alpha-"Armed" TCR Vectors to Enhance Adoptive Cell Therapy for Solid Tumors
National Cancer Institute · R37
Contact PI · $1.3M · University of California Los Angeles
2025–2030
Functional Epigenomics of Transgenic Cellular Immunotherapies for Cancer
National Cancer Institute · K08
Contact PI · $909.4K · University of California Los Angeles
2021–2026

Clinical trials

Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer
Principal investigator · Terminated · Phase 1
Jonsson Comprehensive Cancer Center
2017–2023